Stockscreener 앱 받기
7.82
1.30%
0.10
Instil Bio Inc 주식(TIL)의 최신 뉴스
Bronstein, Gewirtz & Grossman, LLC Encourages Instil Bio, Inc. (T - The National Law Review
Discipline and Rules-Based Execution in TIL Response - Stock Traders Daily
Enterprise value to EBIT forward of Instil Bio, Inc. – NASDAQ:TIL - TradingView
Price to sales forward of Instil Bio, Inc. – NASDAQ:TIL - TradingView
Instil Bio, Inc. Actuals & Estimates (NASDAQ:TIL) - TradingView
5GT0 Forecast — Price Target — Prediction for 2027 - TradingView
TIL Forecast — Price Target — Prediction for 2027 - TradingView
Instil Bio Inc (TIL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Instil Bio Inc (TIL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Instil Bio Inc (TIL) Valuation: PE, PB & Fair Value Analysis - TradingKey
Behavioral Patterns of TIL and Institutional Flows - Stock Traders Daily
Instil Bio Inc (TIL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Instil Bio Inc (TIL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Instil Bio Inc (TIL) Institutional Confidence - TradingKey
Instil Bio Inc (TIL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Instil Bio Inc (TIL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Instil Bio Inc (TIL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Instil Bio (TIL) director awarded stock options for 6,500 shares at $7.93 - Stock Titan
Instil Bio (NASDAQ: TIL) director receives grant of 6,500 stock options - Stock Titan
Instil Bio (TIL) director awarded 6,500 stock options at $7.93 strike - Stock Titan
Instil Bio (TIL) director Gwendolyn Binder awarded 6,500 stock options at $7.93 - Stock Titan
Instil Bio Shareholders Back Directors and Auditor at Meeting - TipRanks
[8-K] Instil Bio, Inc. Reports Material Event - Stock Titan
Instil Bio Inc. (TIL) Edges Lower as Stock Tests Key Support ZoneWave Truncation - newsline.com
Instil Bio Inc. Q1 2026 Earnings: EPS Misses Estimates Amid No RevenueBasic EPS Analysis - newsline.com
TIL Q1 2026 Earnings: Wider-than-Expected Loss Reflects Continued R&D Investment Amid No RevenueEPS Growth Rate - newsline.com
(TIL) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
TIL Technical Analysis | Trend, Signals & Chart Patterns | INSTIL BIO INC (NASDAQ:TIL) - ChartMill
TIL Q1 2026 Earnings: Wider-than-Expected Loss as Pre-Revenue Biotech Navigates Early PipelineEstimate Accuracy - newsline.com
TILInstil Bio Inc Stock Price and Quote - Finviz
How (TIL) Movements Inform Risk Allocation Models - Stock Traders Daily
TIL News | INSTIL BIO INC (NASDAQ:TIL) - ChartMill
TIL Q1 2026 Earnings: Wider-than-Expected Loss Highlights Early-Stage Development ChallengesCapex Guidance - The Legal Advocate
Instil Bio Inc. (TIL) Holds Steady Near Key Support After Modest UptickShort Setup Alerts - The Legal Advocate
Instil Bio Q1 2026 Earnings: EPS Miss as Development-Stage Company Reports No Revenue; Stock Edges UpROA Comparison - The Legal Advocate
Instil Bio Q1 2026 Earnings: EPS Miss Reflects Ongoing R&D InvestmentFinancial Health Score - The Legal Advocate
Instil Bio Inc. (TIL) Q1 2026 Earnings: Wider-Than-Expected Loss as Biotech Continues Pre-Commercial PhaseFree Market Insights - Newser
Instil Bio (TIL) Q1 2026 Results Fall Short — EPS $-0.62, Revenue $N/AStock Idea Network - Newser
Trading Systems Reacting to (TIL) Volatility - Stock Traders Daily
Instil Bio (TIL) Q4 2025 Beat: Revenue $N/A, EPS Exceeds by SignificantMargin Improvement - Newser
Instil Bio Releases Q1 2026 Financial Results - AlphaStreet
Instil Bio, Inc. Reports First Quarter 2026 Financial Results – 8-K Filing Details and Key Highlights - Minichart
Instil Bio Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Instil Bio, Inc. 1Q 2026: Net loss $4.2M, EPS $(0.62) — 10-Q Summary - TradingView
Instil Bio (NASDAQ: TIL) cuts Q1 loss as 2024 loan and going concern risk loom - Stock Titan
Instil Bio (Nasdaq: TIL) trims Q1 2026 loss and extends cash runway beyond 2027 - Stock Titan
Instil Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update - The Manila Times
BRIEF-Instil Bio Q1 Basic EPS USD -0.62 - TradingView
TradingKey - TradingKey
MSN Money - MSN
Why Instil Bio (TIL) deserves a deeper look right now (Smart Money Flows) 2026-05-08AI Powered Stock Picks - Newser
Instil Bio Inc expected to post a loss of 59 cents a shareEarnings Preview - TradingView
How Instil Bio Inc. (TIL) Affects Rotational Strategy Timing - Stock Traders Daily
The R&D spending story behind Instil Bio (TIL) innovation | Instil Bio posts 41% EPS beat, narrower loss, no revenueDebt/EBITDA - newser.com
Instil Bio posts 41% EPS beat, narrower loss, no revenueFinal Results - The Legal Advocate
1.95%
2.70%
자본화:
|
볼륨(24시간):